Flow cytometry in clinical cancer research

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

Leukemia·2018

Drug response prediction in high-risk multiple myeloma.

Gene·2017

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Nature communications·2017

Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.

Leukemia·2017

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker.

Blood cancer journal·2017

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma.

Leukemia·2016

Matrix Stiffness-Encoded Mechanical Memory Maintains Proliferative Dominance in Metastatic Tumors.

Cancer research·2026

Multiomics Dissection Reveals Natural Killer Cell-CD8+ T-cell Cooperation in Shaping an Immunostimulatory Tumor Microenvironment.

Cancer research·2026

A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells.

Cancer research·2026

CDState Resolves Malignant Cell Heterogeneity from Bulk Tumor RNA-Sequencing Data.

Cancer research·2026

ETV6 Rearrangement Suppresses CDKN1B Transcription by Disrupting an Intragenic Super-Enhancer in Acute Lymphoblastic Leukemia.

Cancer research·2026

KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer.

Cancer research·2026

Elucidating the Nexus of Mitochondrial Dysfunction and Oncometabolite Accumulation in Tumorigenesis.

Nigerian medical journal : journal of the Nigeria Medical Association·2026

Innate Immune Cells in Non-Small Cell Lung Cancer: Roles in Tumor Progression and Therapeutic Responses.

Cancer innovation·2026

Integrating multi-omics data reveals IL-8 positive cancer-associated fibroblasts as mediators of chemotherapy-induced tumor progression in breast cancer.

Frontiers in immunology·2026

Spatially resolved tissue architecture and computational pathology in pancreatic cancer.

Experimental & molecular medicine·2026

CHRNA5 orchestrates tumorigenesis and immune invasion through the CaMKII/AKT/NF-κB-CCL20 axis in pancreatic ductal adenocarcinoma.

Life sciences·2026

Deciphering the colorectal tumor microenvironment: Interactions and targets for effective therapy.

Biochemical pharmacology·2026

Related Experiment Videos

Flow cytometry in clinical cancer research

Related Concept Videos

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

Drug response prediction in high-risk multiple myeloma.

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker.

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma.

Matrix Stiffness-Encoded Mechanical Memory Maintains Proliferative Dominance in Metastatic Tumors.

Multiomics Dissection Reveals Natural Killer Cell-CD8+ T-cell Cooperation in Shaping an Immunostimulatory Tumor Microenvironment.

A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells.

CDState Resolves Malignant Cell Heterogeneity from Bulk Tumor RNA-Sequencing Data.

ETV6 Rearrangement Suppresses CDKN1B Transcription by Disrupting an Intragenic Super-Enhancer in Acute Lymphoblastic Leukemia.

KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer.

Elucidating the Nexus of Mitochondrial Dysfunction and Oncometabolite Accumulation in Tumorigenesis.

Innate Immune Cells in Non-Small Cell Lung Cancer: Roles in Tumor Progression and Therapeutic Responses.

Integrating multi-omics data reveals IL-8 positive cancer-associated fibroblasts as mediators of chemotherapy-induced tumor progression in breast cancer.

Spatially resolved tissue architecture and computational pathology in pancreatic cancer.

CHRNA5 orchestrates tumorigenesis and immune invasion through the CaMKII/AKT/NF-κB-CCL20 axis in pancreatic ductal adenocarcinoma.

Deciphering the colorectal tumor microenvironment: Interactions and targets for effective therapy.

Related Experiment Videos

Flow cytometry in clinical cancer research

Related Concept Videos

Related Articles